Alkermes (NASDAQ: ALKS) reported Q1 EPS of $0.13, $0.18 worse than the analyst estimate of $0.31. Revenue for the quarter came in at $306.5 million versus the consensus estimate of $309.51 million.

For earnings history and earnings-related data on Alkermes (ALKS) click here.